BiotechTube
Home/Mustang Bio/Greg Furrow, M.S., FRQA
GF

Greg Furrow, M.S., FRQA

Chief Quality Officer

Mustang Bio

Therapeutic Areas

Oncology

Mustang Bio Pipeline

DrugIndicationPhase
MB-101High-Grade Glioma / GlioblastomaPhase 1
MB-106Relapsed/Refractory B-cell NHL & CLLPhase 1/2
MB-108Glioblastoma / Malignant GliomaPhase 1

Leadership Team at Mustang Bio

ML
Manuel Litchman, M.D.
President, Chief Executive Officer and Director
MS
Michael S. Weiss
Chairman of the Board of Directors
LA
Lindsay A. Rosenwald, M.D.
Director
AJ
Adam J. Chill
Director
View full Mustang Bio profile